Two Sigma Securities, LLC Cidara Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

  • $10.3 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.68 - $0.97 $24,943 - $35,580
36,681 New
36,681 $28,000
Q1 2023

May 15, 2023
BUY
$0.75 - $1.98 $8,694 - $22,952
11,592 New
11,592 $14,000
Q3 2022

Nov 14, 2022
BUY
$0.45 - $0.81 $18,818 - $33,873
41,819 New
41,819 $26,000
Q3 2019

Nov 14, 2019
SELL
$1.25 - $2.35 $16,130 - $30,324
-12,904 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$1.49 - $2.94 $19,226 - $37,937
12,904 New
12,904 $22,000

Others Institutions Holding CDTX

# of Institutions
52
Shares Held
22.1M
Call Options Held
2.7K
Put Options Held
100
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $889M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email